Search Results - "de Baptista, E A"

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives by Baptista, T, Kin, N M K N Y, Beaulieu, S, de Baptista, E A

“…Excessive body weight gain (BWG) is a common side effect of some typical and atypical antipsychotic drugs (APs). Convergent evidence suggests a hierarchy in…”
Get more information

Comparative effects of the antipsychotics sulpiride or risperidone in rats: I: Bodyweight, food intake, body composition, hormones and glucose tolerance by Baptista, Trino, Araujo de Baptista, Emma, Ying Kin, N.M.K.Ng, Beaulieu, Serge, Walker, Dominique, Joober, Rhida, Lalonde, Josee, Richard, Denis

“…Obesity and related metabolic disorders are important side effects of some antipsychotic drugs (APs). The currently available animal model of AP-induced…”
Get full text

Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection by Baptista, Trino, de Baptista, Emma Araujo, Lalonde, Josee, Plamondon, Julie, Kin, N.M.K. Ng Ying, Beaulieu, Serge, Joober, Rhida, Richard, Denis

“…Previous studies showed that the antipsychotic drugs (APDs) sulpiride (SUL) and risperidone (RIS) induced body weight gain (BWG), hyperphagia, and increased…”
Get full text

Tamoxifen Prevents Sulpiride-Induced Weight Gain in Female Rats by Baptista, Trino, de BAPTISTA, Enma Araujo, Hernandez, Luis, Altemus, Marty, Weiss, Susan R

“…To evaluate its potential utility in counteracting neuroleptic-induced obesity, the effects of long-term administration of tamoxifen (TAM) on body weight (BW)…”
Get full text

Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation by Baptista, T, Alastre, T, Contreras, Q, Martinez, J L, Araujo de Baptista, E, Páez, X, Hernández, L

“…Metabolic and endocrine abnormalities secondary to hyperprolactinemia, particularly hypogonadism, may be involved in the excessive body weight gain observed…”
Get more information

Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates by Baptista, T, López, M E, Teneud, L, Contreras, Q, Alastre, T, de Quijada, M, Araujo de Baptista, E, Alternus, M, Weiss, S R, Musseo, E, Páez, X, Hernández, L

“…The efficacy of the antiviral agent Amantadine (AM, 5-100 mg/kg/sc, ip or intrahypothalamically, 12.5-100 micrograms bilaterally) in influencing body weight…”
Get more information